[EN] SILICATE PRODRUGS AND NANOPARTICLES<br/>[FR] PROMÉDICAMENTS ET NANOPARTICULES DE SILICATE
申请人:UNIV MINNESOTA
公开号:WO2012166949A1
公开(公告)日:2012-12-06
The invention provides silicate prodrugs comprising a therapeutic agent linked to one or more groups of formula (I): -Si(OR)3 (I); wherein each R independently has any of the values defined herein, as well as nanoparticles comprising such compounds.
Silicate Esters of Paclitaxel and Docetaxel: Synthesis, Hydrophobicity, Hydrolytic Stability, Cytotoxicity, and Prodrug Potential
作者:Adam R. Wohl、Andrew R. Michel、Stephen Kalscheuer、Christopher W. Macosko、Jayanth Panyam、Thomas R. Hoye
DOI:10.1021/jm401708f
日期:2014.3.27
report here the synthesis and selected properties of various silicate ester derivatives (tetraalkoxysilanes) of the taxanes paclitaxel (PTX) and docetaxel (DTX) [i.e., PTX-OSi(OR)3 and DTX-OSi(OR)3]. Both the hydrophobicity and hydrolytic lability of these silicates can be (independently) controlled by choice of the alkyl group (R). The synthesis, structural characterization, hydrolytic reactivity, and